Can antiviral therapy for chronic hepatitis B enhance the progression to hepatocellular carcinoma?

被引：1
|
作者：
Warner, Nadia [1 ]
Locarnini, Stephen [1 ]
机构：
[1] Victorian Infect Dis Reference Labs, Melbourne, Vic, Australia
来源：
ANTIVIRAL THERAPY | 2009年 / 14卷 / 02期
关键词：
VIRUS-DNA; TRANSMEMBRANE TOPOLOGY; TRANSCRIPTIONAL TRANSACTIVATOR; LAMIVUDINE THERAPY; PRES/S-SEQUENCES; SURFACE-ANTIGEN; YMDD-MOTIF; INFECTION; REGION; GENOTYPE;
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：139 / 142
页数：4
相关论文
共 50 条
  • [11] Antiviral therapy is not enough to prevent hepatocellular carcinoma development in patients with chronic hepatitis B
    Koklu, Seyfettin
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2014, 25 (01): : 124 - 124
  • [12] The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
    Varbobitis, Ioannis
    Papatheodoridis, George V.
    CLINICAL AND MOLECULAR HEPATOLOGY, 2016, 22 (03) : 319 - 326
  • [13] Antiplatelet Therapy and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients on Antiviral Treatment
    Lee, Minjong
    Chung, Goh Eun
    Lee, Jeong-Hoon
    Oh, Sohee
    Nam, Joon Yeul
    Chang, Young
    Cho, Hyeki
    Ahn, Hongkeun
    Cho, Young Youn
    Yoo, Jeong-ju
    Cho, Yuri
    Lee, Dong Hyeon
    Cho, Eun Ju
    Yu, Su Jong
    Lee, Dong Ho
    Lee, Jeong Min
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    HEPATOLOGY, 2017, 66 (05) : 1556 - 1569
  • [14] Averting Hepatocellular Carcinoma in Chronic Hepatitis B With Antiviral Therapy: Tipping the Balance or Not Yet?
    Janssen, Harry L. A.
    Arif, Ambreen
    GASTROENTEROLOGY, 2014, 147 (01) : 24 - 26
  • [15] Antiviral therapy and risk for hepatocellular carcinoma in chronic viral hepatitis
    Abdurakhmanov, D. T.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (10) : 94 - 97
  • [16] Slowing the progression of chronic hepatitis B - Early antiviral therapy can help minimize complications
    Purow, DB
    Jacobson, IM
    POSTGRADUATE MEDICINE, 2003, 114 (01) : 65 - +
  • [17] Hepatocellular Carcinoma Risk In Chronic Hepatitis B Patients Achieving Viral Suppression With Antiviral Therapy
    Ghaly, Simon
    Gill, Raghubinder S.
    Keegan, Mathew J.
    Angus, Peter W.
    George, Jacob
    Nicoll, Amanda J.
    Law, Matthew
    Sinclair, Marie
    Lim, Lucy Y.
    Ratnayake, Hasanka
    Dunn, Anna
    Strasser, Simone I.
    Zekry, Amany
    HEPATOLOGY, 2012, 56 : 354A - 354A
  • [18] RISK FACTORS FOR THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA AFTER ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS B PATIENTS
    Chen, Junjie
    Feng, Tienan
    Zhang, Xinxin
    HEPATOLOGY, 2023, 78 : S491 - S492
  • [19] Antiviral Therapy for Chronic Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma in a US Population
    Gordon, Stuart C.
    Lamerato, Lois E.
    Rupp, Loralee B.
    Li, Jia
    Holmberg, Scott D.
    Moorman, Anne C.
    Spradling, Philip R.
    Teshale, Eyasu H.
    Vijayadeva, Vinutha
    Boscarino, Joseph A.
    Henkle, Emily M.
    Oja-Tebbe, Nancy
    Lu, Mei
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (05) : 885 - 893
  • [20] Association of central obesity with hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy
    Fan, Rong
    Niu, Junqi
    Ma, Hong
    Xie, Qing
    Cheng, Jun
    Rao, Huiying
    Dou, Xiaoguang
    Xie, Jianping
    Zhao, Wei
    Peng, Jie
    Gao, Zhiliang
    Gao, Hongbo
    Chen, Xinyue
    Chen, Jinjun
    Li, Qiang
    Tang, Hong
    Zhang, Zhengang
    Ren, Hong
    Cheng, Mingliang
    Liang, Xieer
    Zhu, Chaonan
    Wei, Lai
    Jia, Jidong
    Sun, Jian
    Hou, Jinlin
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (03) : 329 - 338
12345